Global and United States Nivolumab Market Report & Forecast 2024-2031

Report ID: 1869234 | Published Date: Jan 2025 | No. of Page: 78 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Nivolumab Product Introduction
    1.2 Global Nivolumab Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Nivolumab Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Nivolumab Sales in Volume for the Year 2017-2028
    1.3 United States Nivolumab Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Nivolumab Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Nivolumab Sales in Volume for the Year 2017-2028
    1.4 Nivolumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Nivolumab in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Nivolumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Nivolumab Market Dynamics
        1.5.1 Nivolumab Industry Trends
        1.5.2 Nivolumab Market Drivers
        1.5.3 Nivolumab Market Challenges
        1.5.4 Nivolumab Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Nivolumab Market Segment by Type
        2.1.1 Injection 4mL
        2.1.2 Injection 10mL
    2.2 Global Nivolumab Market Size by Type
        2.2.1 Global Nivolumab Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Nivolumab Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Nivolumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Nivolumab Market Size by Type
        2.3.1 United States Nivolumab Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Nivolumab Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Nivolumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Nivolumab Market Segment by Application
        3.1.1 Unresectable Melanoma
        3.1.2 Metastatic Melanoma
        3.1.3 Metastatic Squamous NSCLC
        3.1.4 Classical Hodgkin Lymphoma
        3.1.5 Renal Cell Carcinoma
        3.1.6 Other
    3.2 Global Nivolumab Market Size by Application
        3.2.1 Global Nivolumab Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Nivolumab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Nivolumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Nivolumab Market Size by Application
        3.3.1 United States Nivolumab Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Nivolumab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Nivolumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Nivolumab Competitor Landscape by Company
    4.1 Global Nivolumab Market Size by Company
        4.1.1 Top Global Nivolumab Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Nivolumab Revenue by Manufacturer (2017-2022)
        4.1.3 Global Nivolumab Sales by Manufacturer (2017-2022)
        4.1.4 Global Nivolumab Price by Manufacturer (2017-2022)
    4.2 Global Nivolumab Concentration Ratio (CR)
        4.2.1 Nivolumab Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Nivolumab in 2021
        4.2.3 Global Nivolumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Nivolumab Manufacturing Base Distribution, Product Type
        4.3.1 Global Nivolumab Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Nivolumab Product Type
        4.3.3 Date of International Manufacturers Enter into Nivolumab Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Nivolumab Market Size by Company
        4.5.1 Top Nivolumab Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Nivolumab Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Nivolumab Sales by Players (2020, 2021 & 2022)
5 Global Nivolumab Market Size by Region
    5.1 Global Nivolumab Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Nivolumab Market Size in Volume by Region (2017-2028)
        5.2.1 Global Nivolumab Sales in Volume by Region: 2017-2022
        5.2.2 Global Nivolumab Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Nivolumab Market Size in Value by Region (2017-2028)
        5.3.1 Global Nivolumab Sales in Value by Region: 2017-2022
        5.3.2 Global Nivolumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Nivolumab Market Size YoY Growth 2017-2028
        6.1.2 North America Nivolumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Nivolumab Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Nivolumab Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Nivolumab Market Size YoY Growth 2017-2028
        6.3.2 Europe Nivolumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Nivolumab Market Size YoY Growth 2017-2028
        6.4.2 Latin America Nivolumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Nivolumab Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Nivolumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Ono Pharmaceutical
        7.1.1 Ono Pharmaceutical Corporation Information
        7.1.2 Ono Pharmaceutical Description and Business Overview
        7.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Ono Pharmaceutical Nivolumab Products Offered
        7.1.5 Ono Pharmaceutical Recent Development
    7.2 Bristol-Myers Squibb
        7.2.1 Bristol-Myers Squibb Corporation Information
        7.2.2 Bristol-Myers Squibb Description and Business Overview
        7.2.3 Bristol-Myers Squibb Nivolumab Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Bristol-Myers Squibb Nivolumab Products Offered
        7.2.5 Bristol-Myers Squibb Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Nivolumab Industry Chain Analysis
    8.2 Nivolumab Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Nivolumab Distributors
    8.3 Nivolumab Production Mode & Process
    8.4 Nivolumab Sales and Marketing
        8.4.1 Nivolumab Sales Channels
        8.4.2 Nivolumab Distributors
    8.5 Nivolumab Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Nivolumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Nivolumab Market Trends
    Table 3. Nivolumab Market Drivers
    Table 4. Nivolumab Market Challenges
    Table 5. Nivolumab Market Restraints
    Table 6. Global Nivolumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Nivolumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Nivolumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Nivolumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Nivolumab Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Nivolumab Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Nivolumab Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Nivolumab Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Nivolumab Sales Share by Manufacturer, 2017-2022
    Table 15. Global Nivolumab Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Nivolumab Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Nivolumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab as of 2021)
    Table 18. Top Players of Nivolumab in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Nivolumab Product Type
    Table 20. Date of International Manufacturers Enter into Nivolumab Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Nivolumab Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Nivolumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Nivolumab Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Nivolumab Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Nivolumab Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Nivolumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Nivolumab Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Nivolumab Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Nivolumab Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Nivolumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Nivolumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Nivolumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Nivolumab Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Nivolumab Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Nivolumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Nivolumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Nivolumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Nivolumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Nivolumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Nivolumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Ono Pharmaceutical Corporation Information
    Table 43. Ono Pharmaceutical Description and Business Overview
    Table 44. Ono Pharmaceutical Nivolumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Ono Pharmaceutical Nivolumab Product
    Table 46. Ono Pharmaceutical Recent Development
    Table 47. Bristol-Myers Squibb Corporation Information
    Table 48. Bristol-Myers Squibb Description and Business Overview
    Table 49. Bristol-Myers Squibb Nivolumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Bristol-Myers Squibb Product
    Table 51. Bristol-Myers Squibb Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Nivolumab Customers List
    Table 55. Nivolumab Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nivolumab Product Picture
    Figure 2. Global Nivolumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Nivolumab Market Size 2017-2028 (US$ Million)
    Figure 4. Global Nivolumab Sales 2017-2028 (K Pcs)
    Figure 5. United States Nivolumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Nivolumab Market Size 2017-2028 (US$ Million)
    Figure 7. United States Nivolumab Sales 2017-2028 (K Pcs)
    Figure 8. United States Nivolumab Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Nivolumab Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Nivolumab Report Years Considered
    Figure 11. Product Picture of Injection 4mL
    Figure 12. Product Picture of Injection 10mL
    Figure 13. Global Nivolumab Market Share by Type in 2022 & 2028
    Figure 14. Global Nivolumab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Nivolumab Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Nivolumab Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Nivolumab Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Nivolumab Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Nivolumab Market Share by Type in 2022 & 2028
    Figure 20. United States Nivolumab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Nivolumab Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Nivolumab Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Nivolumab Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Nivolumab Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Unresectable Melanoma
    Figure 26. Product Picture of Metastatic Melanoma
    Figure 27. Product Picture of Metastatic Squamous NSCLC
    Figure 28. Product Picture of Classical Hodgkin Lymphoma
    Figure 29. Product Picture of Renal Cell Carcinoma
    Figure 30. Product Picture of Other
    Figure 31. Global Nivolumab Market Share by Application in 2022 & 2028
    Figure 32. Global Nivolumab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Nivolumab Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Nivolumab Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Nivolumab Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Nivolumab Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Nivolumab Market Share by Application in 2022 & 2028
    Figure 38. United States Nivolumab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Nivolumab Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Nivolumab Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Nivolumab Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Nivolumab Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Nivolumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Nivolumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Nivolumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Nivolumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Nivolumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Nivolumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Nivolumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Nivolumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Nivolumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Nivolumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Nivolumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Nivolumab Value Chain
    Figure 77. Nivolumab Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ono Pharmaceutical
Bristol-Myers Squibb
Frequently Asked Questions
Nivolumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nivolumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nivolumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Durvalumab

Durvalumab market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Pembrolizumab

Pembrolizumab market is segmented by region (country), players, by Type and by Application. Playe ... Read More

Atezolizumab

Atezolizumab market is segmented by region (country), players, by Type and by Application. Player ... Read More

Avelumab

Avelumab market is segmented by region (country), players, by Type and by Application. Players, s ... Read More